However, further research is warranted to develop comprehensive, evidence-based guidelines that fully harness this synergy, maximising therapeutic benefits while minimising associated risks
Ozempic's approval is strictly for type 2 diabetes, whereas Wegovy is validated for weight management
STEP Clinical Trial Program The landmark STEP (Semaglutide Treatment Effect in People with obesity) clinical trial program represents the most extensive investigation of semaglutide for weight management: STEP 1 (New England Journal of Medicine): Enrolled 1,961 adults with obesity or overweight and demonstrated a mean weight loss of 14.9% from baseline at 68 weeks with semaglutide 2.4 mg compared to 2.4% with placebo
For flexibility and a weight-loss guarantee, Shed is a strong runner-up at #2
Suspected adverse drug reactions to any medicine can also be reported directly to the MHRA via the Yellow Card Scheme at yellowcard.mhra.gov.uk or through the Yellow Card app
Cycle 8 weeks on, 8-10 weeks off